Immunomedics (IMMU) - moderated Message Board

To: stockdoc77 who wrote (14995)	6/10/2011 2:34:36 PM
From: corndog	Read Replies (1) of 20748

Doc, you are absolutely correct that the record is not stellar. Two caveats: (1) I am not pleased with the market as a whole or with IMMU PPS in the last 2 weeks and (2) I have not drank any more Kool Aid. Given that, I believe IMMU will have several shots on goal in time. Because of the pipeline and given management's track record, we will probably first hear of a licensing deal which will equate to relatively small dollars up front. We might tend to read that as "look at what they did now!" I think a much larger deal - $50 million or more up front - will be announced subsequently and will provide (a) some operating cash to advance some trials and (b) pressure to move the stock to the $5 range ultimately which may trigger some interesting covering. Why? I don't think analysts of the caliber of Oppenheimer, Wedbush and Cowen would come out with recommendations if there weren't significant opportunities in the works. My "feel" is based on THEIR integrity and analysis ... as well as the science ... not based on IMMU's management abilities or lack thereof ... Just my thoughts ... Dawg